Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;45(1):46-52.
doi: 10.2478/v10019-010-0054-4. Epub 2010 Dec 31.

Triple negative breast cancer - prognostic factors and survival

Tanja Ovcaricek  1 , Snjezana Grazio Frkovic, Erika Matos, Barbara Mozina, Simona Borstnar
Affiliations

Triple negative breast cancer - prognostic factors and survival

Tanja Ovcaricek et al. Radiol Oncol. 2011 Mar.

Abstract

Background: Triple negative breast cancer (TNBC) is defined by a lack of expression of both estrogen (ER) and progesteron (PgR) receptors as well as human epidermal growth factor receptor 2 (HER2). Our retrospective analysis addressed prognostic factors for short- and long-term outcomes of patients (pts) with TNBC pts treated in routine clinical practice. PATIENT AND METHODS.: Our retrospective study included 269 TNBC treated at Institute of Oncology Ljubljana between March 2000 and December 2006. The collected data included patients', tumours' and treatments' characteristics. The survival analyses were performed using the Kaplan-Meier method. The Cox proportional hazard model was used in the multivariate analysis.

Results: The median age of our patients was 55.3 yrs (23-88.5) and the median follow-up was 5.9 yrs (0.3-9.6). Six (2%) pts experienced local only, 79 (92%) pts distal recurrence and 66 (24%) died. The predominant localisation of the first relapse was in visceral organs (70.4%). The 5-year disease-free survival (DFS) for the entire group was 68.2% and the 5-year overall survival (OS) was 74.5%. We found a pattern of high recurrence rate in the first 3 years following the diagnosis and a clear decline in recurrence rate over the next 3 years. In the univariate analysis age, nodal status, size and lymphovascular invasion (LVI) were found to have a significant impact on DFS as well as on OS. In the multivariate analysis only age (HR=1.79; 95%CI=1.14-2.82; p=0.012) and nodal status (HR=2.71; 95%CI=1.64-4.46; p<0.001) retained their independent prognostic value for DFS and for OS only the nodal status (HR=2.96; 95%CI=1.51-5.82; p=0.002).

Conclusions: In our series of TNBC pts nodal status and age (older than 65 yrs) were found to be independent prognostic factors for DFS, whereas for OS only the nodal status. We found a pattern of a high recurrence rate in the first 3 years following the diagnosis and a decline in the recurrence rate over the next 3 yrs with higher rate of distal versus local recurrence and a predominant localization of distal metastases in visceral organs.

Keywords: prognostic factors; treatment outcome; triple negative breast cancer.

PubMed Disclaimer

Conflict of interest statement

Disclosure: No potential conflicts of interest were disclosed.

Figures

FIGURE 1.
FIGURE 1.
Disease-free survival (DFS) in 269 triple negative breast cancer (TNBC) patients.
FIGURE 2.
FIGURE 2.
Overall survival (OS) in 269 triple negative breast cancer (TNBC) patients.
See this image and copyright information in PMC

References

    1. Gluz O, Liedtke C, Gottschalk N, Pustzai L, Nitz U, Harbeck N. Triple-negative breast cancer-current status and future directions. Ann Oncol. 2009;20:1913–27. - PubMed
    1. Podkrajšek M, Žgajnar J, Hočevar M. What is the most common mammographic appearance of T1a and T1b inasive breast cancer? Radiol Oncol. 2008;42:173–80.
    1. Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: Clinical and prognostic implications. Eur J Cancer. 2009;45:27–40. - PubMed
    1. Anders KC, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9(Suppl 2):S73–81. - PMC - PubMed
    1. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403–10. - PubMed